Related Experiment Video
Updated: Jun 4, 2026

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
Published on: September 26, 2025
Graphical process design tools for iontophoretic transdermal drug-delivery devices
1Otto H. York Department of Chemical, Biological and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA. laurent.simon@njit.edu
This study introduces a graphical method for designing iontophoresis-enhanced transdermal drug delivery systems. It optimizes drug concentration and current density for effective steady-state plasma levels.
Area of Science:
- Pharmacology
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Transdermal drug delivery systems (TDDS) offer advantages over conventional routes.
- Iontophoresis can enhance drug permeation through the skin.
- Optimizing TDDS design is crucial for predictable drug release and efficacy.
Purpose of the Study:
- To develop a graphical procedure for the optimal design of iontophoresis-enhanced transdermal drug delivery systems.
- To establish relationships between key design parameters and drug plasma levels.
- To provide a method for predicting system performance without time-domain simulations.
Main Methods:
- Utilized contour plots to visualize relationships between steady-state plasma level, current density, and initial drug concentration.
- Employed a closed-form expression for the process time constant derived from Laplace-transformed variables.
- Performed simulations to validate the graphical procedure and identify optimal parameters.
Main Results:
- A specific current density (0.044 mA/cm²) and drug loading (3500 μg/ml) were determined.
- These parameters achieve an equilibrium plasma concentration of 1.254 ng/cm³.
- The estimated time constant for reaching this plateau was 8.34 hours.
Conclusions:
- The proposed graphical procedure enables efficient and optimum design of iontophoresis-enhanced TDDS.
- The method accurately predicts system performance and facilitates achieving desired steady-state plasma concentrations.
- This approach simplifies the design process by avoiding complex time-domain solutions.
Related Concept Videos
Transdermal Drug Delivery Systems
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Rate-Programmed I
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Modified-Release Drug Delivery Systems: Stimuli-Activated

